Navigation Links
Mirixa Announces Agreement With the Pharmacy Guild of Australia
Date:10/14/2008

MirixaPro(SM) chosen to enable patient care services in Australia through

retail pharmacies nationwide

TAMPA, Fla., Oct. 14 /PRNewswire/ -- NCPA 110th Annual Convention -- Mirixa Corporation, the leader in pharmacy-based patient care services and healthlinks.net, a subsidiary of the Pharmacy Guild of Australia, announced today that they have signed a definitive technology licensing and business consulting agreement, paving the way for the use of MirixaPro(SM) in Australia's pharmacies nationwide. Mirixa Australia, a newly formed business venture, will be operated by the Guild's healthlinks.net subsidiary.

Under the agreement, Mirixa, which is sponsored by the National Community Pharmacists Association (NCPA), will adapt and license its widely used web-based software, MirixaPro(SM), for use by pharmacies in Australia. Additionally, Mirixa's success and leadership in enabling patient care services, through its U.S. network of 46,000 contracted pharmacies, will be leveraged by the Guild as it builds its Australian national program. The Guild will initially deploy Mirixa technology and services to facilitate improved medication adherence and outcomes via programs that harness the power of the pharmacist-patient relationship.

"Medication non-adherence is a challenging and complex global problem that results in poor health and increased health care costs," said Kos Sclavos, National President of the Pharmacy Guild of Australia. "After investigating several options, it became clear that Mirixa's experience and advanced technology provide us with the ability to quickly introduce programs that improve medication adherence and healthcare outcomes in Australia. We are looking forward to working with the Mirixa team to bring technology-enabled services to pharmacists and their patients across Australia," added Mr. Sclavos.

"The partnership between Mirixa and the Pharmacy Guild of Australia is a culmination of years of conversations with our international pharmacy partners. The endorsement of Mirixa and MirixaPro is a testament to our emphasis on the pharmacy and patient care relationship, and the realization of that focus by our partners in Australia," said Bruce T. Roberts, Chief Executive Officer and Executive Vice President, NCPA.

"The Pharmacy Guild of Australia has a widely recognized track record of innovation in technology and services at pharmacy, and we're honored to have them as a business partner," expressed Rick Solano, Mirixa's Chief Executive Officer. "We foresee a bright future of collaboration with the Guild, and look forward to demonstrating the clear value that community pharmacy brings to improving the safety, quality and effectiveness of patient care worldwide," added Mr. Solano.

About Mirixa

Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the healthcare community to deliver patient care services through retail pharmacy. Mirixa's web-based clinical application, MirixaPro(SM), is used by pharmacists to deliver standardized patient care services. For more information, please visit http://www.Mirixa.com.

About The Pharmacy Guild of Australia

The Pharmacy Guild of Australia was established in 1928, bringing together several small retail pharmacy organizations then operating in the various States. Its members are owners of some 4,500 pharmacies throughout Australia. The development of policy is the responsibility of the Guild's supreme governing body, the National Council, on which all State and Territory Branches are represented. Implementation of policy is overseen by the National Executive and effected through the National Secretariat. For more information, please visit http://www.guild.org.au.

About NCPA

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more please visit http://www.ncpanet.org.

Contacts: Christine Ryba Roma Cecere

703.865.2041 61 2 9744 4405

PR@Mirixa.com RCecere@healthlinks.net.au


'/>"/>
SOURCE Mirixa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Mirixa Corporation and the APhA Foundation Form Partnership
2. Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure
3. BioNanomatrix Announces Appointment of Dr. Pui-Yan Kwok to Its Scientific Advisory Board
4. WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
5. Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program
6. CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
7. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
8. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
9. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
10. Pathwork Diagnostics Announces Key Additions to Management Team
11. The Michigan Life Sciences Pipeline Announces The Funding Place(TM) and Other Resources to Connect Investors and Startups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... 1, 2016 asking the Federal Drug Administration (FDA) to consider OA as a ... OARSI is concerned about the growing population of OA patients, many of whom ...
(Date:12/6/2016)... Colorado (PRWEB) , ... December 06, 2016 , ... ... dynamic aqueous plasma technology platforms, announced today that the company has engaged in ... Research and Development Agreement (MRDA) with the CSU Office of the Vice President ...
(Date:12/6/2016)... , Dec. 6, 2016  Creative Medical Technology ... , MD, PhD, FANA, FAAN to the Company,s Scientific ... and clinical trials to assist the Company,s clinical development ... AmnioStem product is a universal donor stem cell derived ... in animal models of stroke 1 .  ...
(Date:12/6/2016)... Australia , Dec. 6, 2016  The ... Informatics Society of Australia (HISA) today announced the ... startup exchange program between Australia ... in the world. HISA and the ... initiating a program to create a global health innovation ...
Breaking Biology Technology:
(Date:12/6/2016)... 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... offering of €500.0 million principal amount of its 1.414% senior ... its 2.425% senior unsecured notes due 2026. ... December 13, 2016, subject to the satisfaction of customary closing conditions.  ... The Company intends to use the ...
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe , ... BioLock , an electrocardiogram (ECG) biosensor analysis ... a key IoT asset. The smart system ensures ... vehicle,s steering wheel and mobile devices to easily ... As vehicle technology advances, so too ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...
Breaking Biology News(10 mins):